Lea James is an associate working in the litigation department of Foley & Lardner LLP. Lea is based in the firm’s Boston office where she is a member of the Business Litigation & Dispute Resolution Practice.
Lea served as a summer associate in the firm’s Milwaukee office in both 2017 and 2018.
Prior to joining Foley, Lea served as a research assistant to Professor Owen Jones at Vanderbilt University Law School and assisted in drafting the new edition of the textbook Law and Neuroscience. Before pursuing her legal career, Lea worked for a contract research organization doing preclinical and clinical research involving pharmaceuticals and medical devices, a role in which she worked with both pharmaceutical companies and the FDA.
Presentations and Publications
- Author, “Pharming Out Data: A Proposal for Promoting Innovation and Public Health through a Hybrid Clinical Data Protection Scheme,” Vanderbilt Journal of Transnational Law (November 2018)
- Co-author, “When a Promise Isn’t Enough—Crafting Proper Employee Patent Assignments,” JD Supra (December 2018)
FDA Allows Pharmacists to Prescribe the COVID-19 Antiviral Paxlovid
The FDA revised its emergency use authorization (EUA) for the COVID-19 antiviral treatment Paxlovid to allow prescribing by pharmacists.
Foley Advises Digital Guardian in Acquisition by HelpSystems
Foley & Lardner LLP served as legal advisor to Digital Guardian, a leader in data loss prevention and managed detection and response, in its acquisition by HelpSystems, a software company focused on information technology.